C-MER MEDICAL (03309) Issues Profit Alert, Anticipates Turnaround with HK$90-110 Million Profit Attributable to Owners in 2025

Stock News03-06

C-MER MEDICAL (03309) has announced that it expects to return to profitability for the fiscal year ending December 31, 2025. The company forecasts a profit attributable to owners ranging between HK$90 million and HK$110 million. This represents a significant improvement compared to the fiscal year 2024, during which the company recorded a loss attributable to owners of HK$135 million.

The anticipated increase in profit is primarily driven by several factors. Revenue is projected to see a slight increase from HK$1.913 billion in fiscal 2024 to approximately HK$1.947 billion in fiscal 2025. The company's strategy to optimize its service network and enhance operational efficiency has yielded significant results, including the closure of underperforming businesses. Furthermore, fiscal 2025 did not see any substantial impairment losses on non-current assets, unlike fiscal 2024, which recorded impairment losses of HK$198 million.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1143235487?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 17:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143235487","market":"sh","top_or_hot":-1,"title":"C-MER MEDICAL (03309) Issues Profit Alert, Anticipates Turnaround with HK$90-110 Million Profit Attributable to Owners in 2025","media":"Stock News","content":"<p>C-MER MEDICAL (03309) has announced that it expects to return to profitability for the fiscal year ending December 31, 2025. The company forecasts a profit attributable to owners ranging between HK$90 million and HK$110 million. This represents a significant improvement compared to the fiscal year 2024, during which the company recorded a loss attributable to owners of HK$135 million.</p>\n<p>The anticipated increase in profit is primarily driven by several factors. Revenue is projected to see a slight increase from HK$1.913 billion in fiscal 2024 to approximately HK$1.947 billion in fiscal 2025. The company's strategy to optimize its service network and enhance operational efficiency has yielded significant results, including the closure of underperforming businesses. Furthermore, fiscal 2025 did not see any substantial impairment losses on non-current assets, unlike fiscal 2024, which recorded impairment losses of HK$198 million.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>C-MER MEDICAL (03309) Issues Profit Alert, Anticipates Turnaround with HK$90-110 Million Profit Attributable to Owners in 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nC-MER MEDICAL (03309) Issues Profit Alert, Anticipates Turnaround with HK$90-110 Million Profit Attributable to Owners in 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-06 17:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>C-MER MEDICAL (03309) has announced that it expects to return to profitability for the fiscal year ending December 31, 2025. The company forecasts a profit attributable to owners ranging between HK$90 million and HK$110 million. This represents a significant improvement compared to the fiscal year 2024, during which the company recorded a loss attributable to owners of HK$135 million.</p>\n<p>The anticipated increase in profit is primarily driven by several factors. Revenue is projected to see a slight increase from HK$1.913 billion in fiscal 2024 to approximately HK$1.947 billion in fiscal 2025. The company's strategy to optimize its service network and enhance operational efficiency has yielded significant results, including the closure of underperforming businesses. Furthermore, fiscal 2025 did not see any substantial impairment losses on non-current assets, unlike fiscal 2024, which recorded impairment losses of HK$198 million.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1516","symbol_name":"腾讯概念","start_time":0,"source_url":"","article_id":"1143235487","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143235487","pubTimestamp":1772788760,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"C-MER MEDICAL (03309) has announced that it expects to return to profitability for the fiscal year ending December 31, 2025. The company forecasts a profit attributable to owners ranging between...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1516":"腾讯概念","03309":"希玛医疗","BK1219":"保健护理服务","BK1209":"保健护理机构"},"translate_title":"C-MER医疗(03309)发盈警，预计2025年拥有人应占溢利9000万-1.1亿港元扭亏为盈","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03309":1},"content_text":"C-MER MEDICAL (03309) has announced that it expects to return to profitability for the fiscal year ending December 31, 2025. The company forecasts a profit attributable to owners ranging between HK$90 million and HK$110 million. This represents a significant improvement compared to the fiscal year 2024, during which the company recorded a loss attributable to owners of HK$135 million.\nThe anticipated increase in profit is primarily driven by several factors. Revenue is projected to see a slight increase from HK$1.913 billion in fiscal 2024 to approximately HK$1.947 billion in fiscal 2025. The company's strategy to optimize its service network and enhance operational efficiency has yielded significant results, including the closure of underperforming businesses. Furthermore, fiscal 2025 did not see any substantial impairment losses on non-current assets, unlike fiscal 2024, which recorded impairment losses of HK$198 million.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1143235487","isCrawlerRequest":true}